143 related articles for article (PubMed ID: 35725945)
1. No sex-based difference in cardiogenic shock: A post-hoc analysis of the DOREMI trial.
Prosperi-Porta G; Motazedian P; Di Santo P; Jung RG; Parlow S; Abdel-Razek O; Simard T; Hutson J; Malhotra N; Fu A; Ramirez FD; Froeschl M; Mathew R; Hibbert B;
J Cardiol; 2022 Oct; 80(4):358-364. PubMed ID: 35725945
[TBL] [Abstract][Full Text] [Related]
2. Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock.
Jung RG; Di Santo P; Mathew R; Abdel-Razek O; Parlow S; Simard T; Marbach JA; Gillmore T; Mao B; Bernick J; Theriault-Lauzier P; Fu A; Lau L; Motazedian P; Russo JJ; Labinaz M; Hibbert B
J Am Heart Assoc; 2021 Nov; 10(21):e021570. PubMed ID: 34713704
[TBL] [Abstract][Full Text] [Related]
3. The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial.
Parlow S; Di Santo P; Mathew R; Jung RG; Simard T; Gillmore T; Mao B; Abdel-Razek O; Ramirez FD; Marbach JA; Dick A; Glover C; Russo JJ; Froeschl M; Labinaz M; Fernando SM; Hibbert B;
Eur Heart J Acute Cardiovasc Care; 2021 Oct; 10(7):712-720. PubMed ID: 34382063
[TBL] [Abstract][Full Text] [Related]
4. Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial.
Di Santo P; Mathew R; Jung RG; Simard T; Skanes S; Mao B; Ramirez FD; Marbach JA; Abdel-Razek O; Motazedian P; Parlow S; Boczar KE; D'Egidio G; Hawken S; Bernick J; Wells GA; Dick A; So DY; Glover C; Russo JJ; McGuinty C; Hibbert B;
Crit Care; 2021 Aug; 25(1):289. PubMed ID: 34376218
[TBL] [Abstract][Full Text] [Related]
5. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Mathew R; Di Santo P; Jung RG; Marbach JA; Hutson J; Simard T; Ramirez FD; Harnett DT; Merdad A; Almufleh A; Weng W; Abdel-Razek O; Fernando SM; Kyeremanteng K; Bernick J; Wells GA; Chan V; Froeschl M; Labinaz M; Le May MR; Russo JJ; Hibbert B
N Engl J Med; 2021 Aug; 385(6):516-525. PubMed ID: 34347952
[TBL] [Abstract][Full Text] [Related]
6. Arrhythmic Events and Mortality in Patients With Cardiogenic Shock on Inotropic Support: Results of the DOREMI Randomized Trial.
Jung RG; Di Santo P; Mathew R; Simard T; Parlow S; Weng W; Abdel-Razek O; Malhotra N; Cheung M; Hutson JH; Marbach JA; Motazedian P; Thibert MJ; Fernando SM; Nery PB; Nair GM; Russo JJ; Hibbert B; Ramirez FD
Can J Cardiol; 2023 Apr; 39(4):394-402. PubMed ID: 36150583
[TBL] [Abstract][Full Text] [Related]
7. Milrinone vs Dobutamine for the Management of Cardiogenic Shock: Implications of Renal Function and Injury.
Di Santo P; Dehghan K; Mao B; Jung RG; Fadare D; Paydar J; Parlow S; Motazedian P; Prosperi-Porta G; Abdel-Razek O; Joseph J; Goh CY; Chung K; Mulloy A; Ramirez FD; Simard T; Hibbert B; Mathew R; Russo JJ
JACC Adv; 2023 Jul; 2(5):100393. PubMed ID: 38938997
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
[TBL] [Abstract][Full Text] [Related]
9. Significant Valvular Dysfunction and Outcomes in Cardiogenic Shock: Insights From the Randomized DOREMI Trial.
Parlow S; Weng W; Di Santo P; Jung RG; Lepage-Ratte MF; Motazedian P; Prosperi-Porta G; Abdel-Razek O; Simard T; Chan V; Labinaz M; Froeschl M; Mathew R; Hibbert B;
Can J Cardiol; 2022 Aug; 38(8):1211-1219. PubMed ID: 35430192
[TBL] [Abstract][Full Text] [Related]
10. Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure.
Rodenas-Alesina E; Luis Scolari F; Wang VN; Brahmbhatt DH; Mihajlovic V; Fung NL; Otsuki M; Billia F; Overgaard CB; Luk A
ESC Heart Fail; 2023 Aug; 10(4):2577-2587. PubMed ID: 37322827
[TBL] [Abstract][Full Text] [Related]
11. Lactate Clearance as a Surrogate for Mortality in Cardiogenic Shock: Insights From the DOREMI Trial.
Marbach JA; Di Santo P; Kapur NK; Thayer KL; Simard T; Jung RG; Parlow S; Abdel-Razek O; Fernando SM; Labinaz M; Froeschl M; Mathew R; Hibbert B
J Am Heart Assoc; 2022 Mar; 11(6):e023322. PubMed ID: 35261289
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock.
Lewis TC; Aberle C; Altshuler D; Piper GL; Papadopoulos J
J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):130-138. PubMed ID: 30175599
[TBL] [Abstract][Full Text] [Related]
13. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
Schumann J; Henrich EC; Strobl H; Prondzinsky R; Weiche S; Thiele H; Werdan K; Frantz S; Unverzagt S
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009669. PubMed ID: 29376560
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of milrinone and dobutamine in low cardiac output states: Systematic review and meta-analysis.
Mathew R; Visintini SM; Ramirez FD; DiSanto P; Simard T; Labinaz M; Hibbert BM
Clin Invest Med; 2019 Jun; 42(2):E26-32. PubMed ID: 31228965
[TBL] [Abstract][Full Text] [Related]
15. Management and clinical outcomes of cardiogenic shock in King Abdulaziz University Hospital: A retrospective study.
Fida HL; Qutub MA; Algazzar AS; AlDharrab AS; Alnajjar TA; Andijani AMA; Taiyeb AM
Saudi Med J; 2023 May; 44(5):479-485. PubMed ID: 37182910
[TBL] [Abstract][Full Text] [Related]
16. Sex-Specific Management in Patients With Acute Myocardial Infarction and Cardiogenic Shock: A Substudy of the CULPRIT-SHOCK Trial.
Rubini Gimenez M; Zeymer U; Desch S; de Waha-Thiele S; Ouarrak T; Poess J; Meyer-Saraei R; Schneider S; Fuernau G; Stepinska J; Huber K; Windecker S; Montalescot G; Savonitto S; Jeger RV; Thiele H
Circ Cardiovasc Interv; 2020 Mar; 13(3):e008537. PubMed ID: 32151161
[TBL] [Abstract][Full Text] [Related]
17. Inotrope and vasopressor use in cardiogenic shock: what, when and why?
Hu K; Mathew R
Curr Opin Crit Care; 2022 Aug; 28(4):419-425. PubMed ID: 35792520
[TBL] [Abstract][Full Text] [Related]
18. Sex Differences in Management and Outcomes of Acute Myocardial Infarction Patients Presenting With Cardiogenic Shock.
Elgendy IY; Wegermann ZK; Li S; Mahtta D; Grau-Sepulveda M; Smilowitz NR; Gulati M; Garratt KN; Wang TY; Jneid H
JACC Cardiovasc Interv; 2022 Mar; 15(6):642-652. PubMed ID: 35331456
[TBL] [Abstract][Full Text] [Related]
19. Gender disparities with the use of percutaneous left ventricular assist device in patients undergoing percutaneous coronary intervention complicated by cardiogenic shock: From pVAD Working Group.
Doshi R; Patel K; Decter D; Jauhar R; Meraj P
Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S90-S95. PubMed ID: 30122245
[TBL] [Abstract][Full Text] [Related]
20. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
Schrage B; Ibrahim K; Loehn T; Werner N; Sinning JM; Pappalardo F; Pieri M; Skurk C; Lauten A; Landmesser U; Westenfeld R; Horn P; Pauschinger M; Eckner D; Twerenbold R; Nordbeck P; Salinger T; Abel P; Empen K; Busch MC; Felix SB; Sieweke JT; Møller JE; Pareek N; Hill J; MacCarthy P; Bergmann MW; Henriques JPS; Möbius-Winkler S; Schulze PC; Ouarrak T; Zeymer U; Schneider S; Blankenberg S; Thiele H; Schäfer A; Westermann D
Circulation; 2019 Mar; 139(10):1249-1258. PubMed ID: 30586755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
